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INTRODUCTION
The prevalence of obesity has reached pandemic proportions
and is a major risk for several metabolic and cardiovascular
diseases. It is believed that this phenomenon is related to an
increased energy intake and reduction of physical activity,
leading to diminished insulin sensitivity, the reduced skeletal
muscle mass and an increase of visceral adipose tissue and
epididymal fat (1-4). Chronic low-grade inflammation,
accompanied by proinflammatory macrophages infiltration in
white adipose tissue (WAT), has been closely correlated with
obesity and its comorbidities (5-8). Adipose tissue, though
historically considered as inert energy storage, has been now
recognized as an endocrine organ due to secretion of an array of
signaling molecules called adipokines (9, 10). Adipokines are
also involved in the regulation of inflammatory responses and
the dysregulation of adipokines secretion might lead to the
development of an excess of adiposity and the decrease of
insulin sensitivity (9-12). On the other hand, it is generally
accepted that regular, moderate physical activity is inversely
correlated with systemic low-grade inflammation supporting the
notion that protective effects of exercise in patients with chronic
diseases could be attributed to the exercise-induced an anti-
inflammatory action (13, 14).
These protective effects of exercise could be due to the
secretion of muscle-derived peptides, so-called 'myokines'
released by contracting skeletal muscles, and exerting a direct
anti-inflammatory effects, and/or specific effects on adipose
tissue (3, 15, 16). Of particular interest is this myokine ability to
modify adipose tissue metabolism and its contribution to a cross-
talk of signals from skeletal muscle and adipose tissue. It was
suggested that skeletal muscle myokines could be of therapeutic
value in chronic diseases in which the exercise has been
demonstrated to exhibit a beneficial effect like obesity, type 2
diabetes, hypertension and others (3, 15). The particularly
promising therapeutic target seems the pathways activated by
irisin, the myokine identified by Bostrom et al. (17). Irisin is a
peptide released into the circulation by cleavage of fibronectin
type III domain containing protein 5 (FNDC5), a membrane-
bound protein in skeletal muscle and released in response to
exercise or muscle shivering, to cause browning and to regulate
the thermogenesis within white adipose tissue (17-19).
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A biological activity of myokine irisin, has been intensively investigated in the context of a browning process occurring
in white adipose tissue, but its role as a modulator of immune response has been little studied. The aim of our study was
to determine the impact of irisin (0 – 100 nM) on pro-inflammatory activation of adipocyte 3T3 L1 cell line. Irisin
reduced in a concentration-dependent manner the expression and activity of major proinflammatory cytokines, e.g.
tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) expression and their secretion into cell medium. Moreover,
irisin enhanced adiponectin synthesis reversing the effect of the lipopolysaccharide (LPS)-induced attenuation of this
adipokine expression. The opposite effect was observed for leptin whose expression increased by LPS and this effect
was suppressed by irisin application. A decreased phosphorylation and activation of nuclear factor kappa B (NFκB) in
the presence of irisin suggests that mechanism of action irisin involves the inhibition of an inflammatory transcription
factor. Irisin exerts also an inhibitory effect on macrophage migration toward chemoattractants present in adipocyte
supernatants. Among the specific molecules secreted by adipocytes was monocyte chemotactic protein 1 (MCP-1)
whose expression was suppressed by irisn. In majority of experiments irisin was effective in 100 nM concentration but
in some of them the inhibitory effects occurred already in a concentration of 50 nM of this peptide. This study for the
first time showed that adipocytes are directly affected by irisin and provides an evidence on anti-inflammatory action of
irisin on fat cells.
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In skeletal muscle FNDC5 expression strictly depends upon
an increased level of PGC-1 peroxisome proliferator-activated
receptor gamma (PPARγ) which is known to regulates genes in
response to nutritional and physiological cues especially to a
physical exercise (20).
It is of the interest that the WAT is not only a target for irisin
action, but also it can be a source of FNDC5 which is
upregulated after exercise (21-24). Recent studies questioned the
existence of irisin in humans (25) but Jedrychowski et al. (26)
using quantitative mass spectrometry confirmed the presence of
human irisin and its release by exercise.
Since irisin exerts a beneficial protective effect in several
tissues, it is believed that irisin possesses also anti-inflammatory
properties, however anti-inflammatory activities of this peptide
are relatively little studied. In some studies anti-inflammatory
action of exercise was associated with increase of plasma irisin
and suggesting that this peptide might be implicated in this
action (27-30). In recent study irisin was shown to decrease the
expression of inflammatory markers by peritoneal macrophages
and stimulate macrophage shift from M1 to M2 types (31). Irisin
was also reported to suppress proinflammatory activation of
macrophages (32, 33) as well as NFκB activation in malignant
breast epithelial cells (34).
While irisin metabolic effect on white adipose tissue has
been well studied and some anti-inflammatory actions have been
shown in other tissues, to our best knowledge this is the first
attempt to characterize the anti-inflammatory effects of irisin in
adipocytes, the main non immunocompetent components of
adipose tissue, which plays a crucial role in pro-inflammatory
activation of macrophages in the obesity state.
MATERIALS AND METHODS
Chemicals and materials
DMEM medium, antibiotics (streptomycin and penicillin),
fetal bovine serum (FBS), and accutase were from PAA
(Pasching, Austria). Lipopolysaccharide (LPS), calf serum, 2',7'-
dichlorodihydrofluorescein diacetate (DCFDA), β-actin
antibody were purchased from Sigma-Aldrich (St. Louis, MO).
Annexin V kit was purchased from BD Biosciences Pharmingen
(San Diego, CA, USA). RNeasy Plus Mini Kit (74134) for RNA
isolation was obtained from Qiagen (Hilden, Germany). High
Capacity RNA-to-cDNA Kit (4387406) for reverse transcription
and TaqMan Gene Expresson Master Mix (4369026) for real
time PCR were provided by Applied Biosystems (ThermoFisher;
Foster City, CA, USA). Phospho-NFκBp65 and total NFκBp65
and secondary antibodies were from Cell Signaling Technology
(Beverly, MA, USA). ELISA kits for TNF-α, IL-6 and leptin
were supplied by IBL International (Hamburg, Germany).
ELISA kits for mouse MCP-1 was purchased from R&D
BioVendor.
Cell culture
The study was conducted in the Mycoplasma-free mouse
preadipocytes 3T3 L1 cell line differentiated to adipocytes. Cell
line was kindly provided by Professor Alicja Jozkowicz from
the Department of Medical Biology, Jagiellonian University.
For the differentiation assessment cells were grown until
confluence in DMEM medium supplemented with 1%
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Fig. 1. The adipocyte activity (A)
and apoptosis (B) after
pretreatment with irisin.
Adipocytes were differentiated
from 3T3 L1 cell line as described
in the Section of Materials and
Methods and then cultured in the
presence of 10 nM (IR10), 50 nM
(IR50) or 100 nM (IR100) of
irisin for 3 weeks. After additional
24 hours of LPS-stimulation (with
LPS groups) or without
stimulation (w/o LPS groups),
CellTiter test (A) or annexin-V
staining (B) were performed
according to a manufacturer's
instruction. Values are means ±
S.D. of 4 – 5 independent
experiments. Asterisk (*; with
LPS groups) and dash (#; w/o
LPS groups) indicate a significant
change as compared with non-
treated (IR0) and irisin (IR10) -
treated cells at P < 0.05 by
Duncan's test.
antibiotic solution and 10% calf serum. After additional 2 days
of culture the growth medium was replaced with differentiation
medium for next 2 days (DMEM medium with 10% fetal bovine
serum, 0.5 mM isobutylmethylxanthine - IBMX, 0.25 µM
dexamethasone). After that period of time the cells were
incubated in a DMEM medium containing 10% FBS and 1
µg/ml insulin until the end of 3-week differentiation process.
Oil-Red-O staining was used for evaluation of adipocyte
differentiation. Then adipocytes were co-cultured with graded
concentrations of irisin (0, 10, 50 or 100 nM) for 3 weeks
labeled as IR0, IR10, IR50 and IR100 groups, respectively. In
order to induce a state of mild inflammation at day 21 cells were
stimulated with LPS (100 ng/ml; Escherichia coli, serotype
0111: B4) or vehicle (medium). During incubation 3T3 L1 cells
were cultured under standard condition (37°C, 5% CO2). Fresh
cells were used for cytometric assessment and RNA isolation.
Supernatants and cell pellets were frozen (–60°C) for future
quantification of protein levels.
Cell activity and viability
Overall cell viability and activity was measured using a
commercial CellTiter kit (Promega). Moreover, the percent of
apoptotic and necrotic cells were quantified cytometrically using
an Annexin V-PE Apoptosis Detection Kit I (BD Pharmingen).
Both tests were performed according to the manufacturer's
instruction using a spectrophotometer (Expert Plus, ASYS/Hitech;
for CellTiter), or a FACScan cytometer (BD Biosciences; for
apoptosis test).
Real-time PCR analysis of gene expression
Total RNA was purified from the 3T3 L1 adipocytes cultured
in four separate repetitions for each variant of the experiment.
RNeasy Plus Mini Kit with elimination of genomic DNA was
used to RNA extraction. The RNA concentration and quality was
assessed using NanoDrop 2000 spectrophotometer (Thermo
Scientific). Reverse transcription was performed using the High
Capacity cDNA Reverse Transcription Kit. Real-time PCR gene
expression analysis for 7 genes (TNF-α, IL-6, adiponectin,
leptin, PPARγ, NFκB, MCP-1) was performed using Applied
Biosystems StepOne system and Taq Man primers. Glucose-6-
phosphate dehydrogenase (GAPDH) was used for normalizing
the amounts of cDNA. Gene expression changes in the presence
of three different doses of irisin were calculated based on 2-∆∆Ct
algorithm (35).
Western blotting assay
To the analysis of total pool of NFκB and its phosphorylated
form as well as PPARγ proteins were extracted from adipocyte
pellets according to the manufacturer's protocol. The protein
concentration was quantified using the BCA protein assay kit.
Then the samples were subjected to the SDS-PAGE gels (10 –
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Fig. 2. The mRNA and protein
expression of proinflammatory
cytokines: TNF-α (A) and IL-6
(B). Adipocytes were
differentiated from 3T3 L1 cell
line as described in the Section of
Materials and Methods and then
co-cultured in the presence of 10
nM (IR10), 50 nM (IR50) or 100
nM (IR100) of irisin for 3 weeks.
After LPS stimulation, adipocytes
were harvested to evaluate the
amount of mRNA transcript (6 h,
real time PCR) or each cytokine
concentration was measured in
cell culture medium (24 hours,
ELISA). Values are means ± S.D.
of 4 – 5 independent experiments.
Asterisk (*, protein) and cross 
(+, mRNA) indicate a significant
change in mRNA and protein
concentration as compared with
non-treated (IR0) and irisin-
treated cells at P < 0.05 by
Duncan's test.
CTR, control (non-activated
adipocytes); IL-6, interleukin 6;
IR, irisin; LPS, lipopoly-
saccharide; TNF-α, tumor
necrosis factor-α
15%), and after electroforetical separation were transferred onto
the PVDF membrane. The nonspecific binding sites were
blocked with 5% dried milk in TBSS for 1 h (37°C) and the
membranes were incubated overnight with primary antibodies
(4°C; 1:1000), and then with secondary antibodies conjugated
with horseradish peroxidase (HRP; 1:5000) for 2 hours at room
temperature. After reaction with DAB, membranes were imaged
and the relative protein expression was normalized to β-actin
expression used as the internal reference.
Macrophage migration
To assess the effect of irisin on a release of chemotactic
factors by activated adipocytes, a 48-well microchemotaxis
chamber (Neuro Probe) and RAW 264.7 macrophage cell line
were used. The test was performed according to the
manufacturer's protocol. Briefly, the lower wells of chamber
were filled with the supernatants collected from 3T3 L1
adipocytes (cultured in the presence of various irisin
concentrations: 0; 10; 50 or 100 nM) 24 hours after LPS
stimulation, control supernatants, fMLP as a positive control, or
DMEM medium as a negative control. The lower wells of
chamber were covered with polycarbonate membrane (3 µm
pore size; Neuro Probe). The upper wells of chamber were filled
with 50 µl of RAW 264.7 macrophages suspension (2 mln/ml)
and incubated for 45 min in standard culture condition. After
that, the membrane was washed in PBS and stained with Diff-
Quick solution (Medion Diagnostic). The macrophages that had
migrated to the lower side of membrane were counted in four
microscopic fields in each well. The results are expressed as the
mean numbers of migratory macrophages per well.
Determination of cytokine/chemokine release
After 24-hours incubation with or without LPS the
supernatants were collected and the levels of cytokine were
quantified using commercial Elisa Kit. The concentration level
of TNF-α, IL-6, MCP-1, adiponectin and leptin was determined
according to the manufacturer's instructions and analyzed using
Expert Plus spectrophotometer (ASYS/Hitech, Austria).
Statistical analysis
Data were tested for normality of the distribution, and
differences among groups were determined using the Duncan's
new multiple range test 3.1. All data were expressed as means ±
standard deviation (S.D.) with the level of statistical significance
(P) set at 0.05.
RESULTS
The influence of irisin on the inflammatory activity of
adipocytes was evaluated in LPS-activated 3T3 L1 cells cultured
in the presence of three different concentrations of irisin (10 nM,
50 nM and 100 nM) in relation to the fat cells not-treated by
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Fig. 3. The expression of mRNA
and secreted protein levels for
adiponectin (A) and leptin (B).
Adipocytes were differentiated
from 3T3 L1 cell line as described
in the Section of Materials and
Methods and then cultured for 
3 weeks in the presence of 10 nM
(IR10), 50 nM (IR50) or 100 nM
(IR100) irisin. After LPS
stimulation, adipocytes were
harvested to evaluate the amount
of adiponectin and leptin mRNA
transcripts (6 h, real time PCR)
and both adipokines
concentration was measured in
cell culture medium (24 h,
ELISA). Values are means ± S.D.
of 4 – 5 independent experiments.
Asterisk (*, protein) and cross (+,
mRNA) indicate a significant
change in mRNA and protein
concentration as compared with
non-treated (IR0) and irisin
(IR10) -treated cells at P < 0.05 by
Duncan's test. CTR, control (non-
activated adipocytes); IR, irisin;
LPS, lipopolysaccharide.
irisin (IR0). As the control to adipocyte activation, the 3T3 L1
cells were treated with medium instead of LPS.
The effects of irisin on adipocyte viability and activity
To assess whether irisin affects the overall activity of the
adipocytes as well as their viability first we performed the study
using a CellTiter test. As shown in Fig. 1A, the incubation of
adipocytes with irisin induced an intensification of general cell
activity in a dose dependent manner. The adipocyte activity was
significantly elevated in both IR50 and IR100 groups (P > 0.05)
as compared to IR0 control cells. This effect was seen in both
LPS-stimulated and non-stimulated adipocytes. Furthermore, to
assess whether the increased activity is related to cell viability,
we performed an examination of irisin impact on apoptosis and
necrosis induction. As shown in Fig. 1B, the highest irisin
concentration (IR100) efficiently inhibited LPS-induced
apoptosis resulting in an increase of lipid droplets accumulation
in these adipocytes (P > 0.05).
Irisin reduces expression and secretion of pro-inflammatory
cytokines
The expression and secretion of two pro-inflammatory
cytokines (TNF-α and IL-6) was assessed in irisin-treated with
two adipocytes compared to irisin-free culture of adipocytes by
the real time PCR and cytokine protein secretion to the culture
medium using enzyme-linked immunosorbent assay (ELISA).
The significant reduction of TNF-α and IL-6 mRNA
expression was observed in 3T3 L1 cells treated by the highest
concentrations of irisin (50 nM and 100 nM) in comparison to
adipocytes treated with vehicle (saline). The concentration of
TNF-α and IL-6 quantified in supernatants were also
significantly reduced when adipocytes were growing in the
presence of 50 nM and 100 nM concentrations of irisin (P <
0.05) (Fig. 2A and 2B).
Effects of irisin on adiponectin and leptin mRNA expression and
protein secretion
Figs. 3A and 3B shows the expression of two major
adipokines: adiponectin and leptin in adipocytes cultured for 
3 weeks in the presence of the three different doses of irisin. The
activation of adipocytes by LPS significantly reduced
adiponectin mRNA and protein expression compared to CTR but
irisin significantly enhanced these expressions nearly to the level
observed in vehicle - control adipocytes (Fig. 3A). In the case of
leptin expression, we have observed an opposite effect because
the activation of adipocytes by LPS significantly increased
mRNA and protein for leptin but irisin administration markedly
decreased its expression both, at mRNA as well as protein levels
resulting comparable value in the presence of 100 nM irisin as in
control (CTR) LPS-untreated cells (Fig. 3B).
PPARγ synthesis is elevated in irisin-treated adipocytes
The co-culture of adipocytes with irisin in a presence of LPS
dose-dependently increased the PPARγ mRNA and protein
expression. The statistically significant differences in expression
of PPARγ mRNA and protein were observed when irisin was
applied in concentration of 50 nM and 100 nM (Fig. 4A). Fig. 4B
shows the representative Western blot of PPARγ protein
expression in response to graded concentrations of irisin in the
presence of LPS. As shown in Fig. 4B the expression of PPARγ
protein was increased in a concentration-dependent manner in
adipocytes co-incubated with irisin.
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Fig. 4. The PPARγ mRNA and protein expression (A) and representative Western blot of PPAR protein expression (B) in irisin-treated
adipocytes exposed to LPS (100 ng/ml). Adipocytes were differentiated from 3T3 L1 cell line as described in the Section of Materials
and Methods and then co-cultured in the presence of 10 nM (IR10), 50 nM (IR50) or 100 nM (IR100) irisin for 3 weeks. After LPS
stimulation, adipocytes were harvested to evaluate the amount of mRNA transcript (6 h, real time PCR) or the protein level (24 h,
Western blotting). Values are means ± S.D. of 5 independent experiments. Asterisk (*, protein) and cross (+, mRNA) indicate 
a significant change in mRNA and protein concentration as compared with non-treated (IR0) and irisin-treated cells at P < 0.05 by
Duncan's test. CTR, control (non-activated adipocytes). IR, irisin; LPS, lipopolysaccharide, PPARγ; peroxisome proliferator-activated
receptor gamma.
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Fig. 5. The effect of irisin on the expression of NFκB in adipocytes exposed to LPS (100 ng/ml). Adipocytes were differentiated from
3T3 L1 cell line as described in the Section of Materials and Methods and then co-cultured in the presence of 10 nM (IR10), 50 nM
(IR50) or 100 nM (IR100) irisin for 3 weeks. After LPS stimulation, adipocytes were harvested to evaluate the amount of total NFκB
protein and phosphorylated form of this protein (6 h, Western blot). Values are means ± S.D. of 4 – 5 independent experiments. Asterisk
(*, total NFκB protein) and cross (+, phosphorylated NFκB protein) indicate a significant change as compared with non-treated (IR0)
and irisin-treated cells at P < 0.05 by Duncan's test. CTR, control (non-activated adipocytes). IR, irisin; LPS, lipopolysaccharide;
NFκB, nuclear factor kappa B.
Irisin attenuates the expression and phosphorylation of NFκB
in activated adipocytes
Fig. 5 shows that NFκB expression was significantly
reduced when adipocytes were co-incubated with irisin in the
concentrations of 50 nM and 100 nM (Fig. 5). When irisin was
co-incubated with adipocytes a significant decrease in the
expression of NFκB was observed at 50 nM and 10 nM of this
peptide (Fig. 5A). The NFκB phosphorylation was significantly
inhibited at the concentration of 100 nM of this peptide.
Macrophage chemotaxis driven by adipocytes is suppressed 
in the presence of irisin
In the final step of our present study we assess the irisin
ability to modify macrophage migration towards
chemoattractants secreted by adipocytes. We found the altered
monocyte chemotactic protein 1 (MCP-1) expression on mRNA
and protein levels in irisin-treated adipocytes in two the highest
doses of irisin but only the highest concentration of irisin namely
100 nM significantly reduced the MCP-1 mRNA and protein
expression (P < 0.05) (Fig. 6A). The irisin-caused changes in
MCP-1 expression were reflected by significantly suppressed
macrophage migration but only in the presence of 100 nM
concentration of irisin (Fig. 6B).
DISCUSSION
In this study, we demonstrated that irisin exerts the marked
anti-inflammatory activity in the lipopolysaccharide-activated
adipocytes.
Regular physical activity has a significant role in the
modulation of immune and anti-infiammation functions
presumably due to myokines released from contracting skeletal
muscle (3). Nowadays, irisin is considered as myokine of
particular interest, released in response to exercise and muscle
shivering. Irisin exerts its action on white adipose, cells causing
their transformation into so called 'bright' cells - white fat cells
with a phenotype similar to that of brown fat cells. Moreover,
irisin has been implicated in process of induction of
thermogenesis and increased energy expenditure (18). Huh et
al. (36) demonstrated that, irisin induced UCP1 and
consequently increased adipocyte energy expenditure, the
expression of metabolic enzymes and metabolite intermediates,
caused an inhibition of lipid accumulation in human adipocytes.
They also observed that irisin and FNDC5 reduced
preadipocyte differentiation, which can be an additional
mechanism in decreasing adiposity (36). Irisin has been shown
to reduce high-fat-diet induced insulin resistance through its
action on WAT and increased energy expenditure (37, 38). Liu
et al. (39) observed that T2D patients had lower plasma irisin
level compared to non-diabetic controls. The possible
therapeutic role has been suggested for irisin in human
metabolic disease, obesity and other disorders to which the
exercise seems to be beneficial (40, 41).
The results of recent study (42) have suggested that obesity
represents a low-grade chronic inflammation in WAT manifested
by hypertrophied adipocytes and increased number of adipose
tissue macrophages (ATM). This inflammation state is
characterized by the activation of pro-inflammatory signaling
pathways and the increased pro-inflammatory cytokine
production (42). Thus, adipocytes are considered since now as
members of the immune system, because they were shown to
produce and release of several pro-inflammatory cytokines and
chemokines such as IL-6, TNF-α, and MCP-1 in addition to
adipokines (43, 44). In obesity, the inflammatory molecules may
originate not only from adipocytes but also from infiltrated
macrophages. This proinflammatory mediators can exhibit local
effect on adipose tissue and also systemic effects on other organs
as well as they contribute to the insulin resistance. Macrophages'
infiltration in white adipose tissue is associated with obesity
causing a phenotypic switch in these cells from an anti-
inflammatory M2 to a pro-inflammatory M1 state (45).
Our results show that irisin reduced expression of pro-
inflammatory cytokines, TNF-α and IL-6 in LPS-activated
adipocytes and this effect depend upon concentration of this
peptide. The similar effect was observed in LPS-activated
peritoneal macrophages (32, 33) because of irisin not only
decreased the expression of TNF-α and IL-6 but also stimulated
macrophage polarization from M1 into M2 response (31).
In line with these inhibitory effects of irisin on pro-
inflammatory cytokines, this peptide has been shown to exert an
opposite effect on adiponectin and leptin expression in LPS-
treated adipocytes. While LPS-activation leads to reduced
adiponectin and increased leptin expression in adipocytes, irisin
was shown in our study to reverse this effect resulting in an
increase in adiponectin and an apparent fall in leptin expression.
Leptin, one of the first proteins shown to be secreted from
adipose tissue, exhibits pro-inflammatory properties and the
concentration of this adipokine is increased in obese subjects
(46). Adiponectin is believed to act as the main anti-inflammatory
mediator produced in and released by adipose tissue. In contrast
to leptin, the expression and plasma levels of adiponectin, the
anti-inflammatory adipokine, are down-regulated in obesity (46).
Recently, TNF-α has been shown to reciprocally increase
the expression of TNF-α and IL-6 and inhibited the expression
of adiponectin in adipocytes, these effects mediated by the
activation of the cellular transcription factor NFκB (47). It is
interesting to note, that in our present study, irisin exerted a
suppressive effect on expression of NFκB in LPS-activated
adipocytes. This observation strongly supports the notion that
irisin exerts an anti-inflammatory action, potentially
counteracting inflammatory cytokines including TNF-α
induced activation of NFκB pathway. Our findings are
consistent with previous studies showing that irisin suppressed
NFκB activation in macrophages (33) and in malignant breast
epithelial cells (34).
Our present study provides an evidence that MCP-1
expression was downregulated in irisin-treated adipocytes
followed by the reduced macrophage migration in the presence
of irisin. Adipocytes were shown to release MCP-1,
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Fig. 6. The mRNA and protein
expression of MCP-1 in
adipocytes exposed to LPS (100
ng/ml) (A) and the macrophage
migration ability (B), are modified
by irisin action. Adipocytes were
differentiated from 3T3 L1 cell
line as described in the section
Materials and Methods and then
co-cultured in the presence of 10
nM (IR10), 50 nM (IR50) or 100
nM (IR100) irisin for 3 weeks.
After LPS stimulation, adipocytes
were harvested to evaluate the
amount of mRNA transcript (6 h,
real time PCR) or cytokine
concentration was measured in
cell culture medium (24 h,
ELISA). Macrophages RAW
264.7 migration to conditioned
medium collected from
adipocytes cultured in the
presence of various
concentrations of irisin for 24
hours. Normal medium was used
as a negative control (CTR-),
fMLP was used as a positive
control (CTR+). Values are means
± S.D. of 4 – 5 independent
experiments. Asterisk (*, protein
and migration) and cross (+,
mRNA) indicate a significant
change as compared with non-
treated (IR0) and irisin-treated
cells (IR10) at P < 0.05 by
Duncan's test. CTR, control (non-
activated adipocytes); IR, irisin;
LPS, lipopolysaccharide; MCP-1,
monocyte chemotactic protein 1.
chemoattractant molecule which is implicated in macrophage
infiltration of WAT (48). Previous studies revealed that when
overexpressing of MCP-1, the WAT leads to an accumulation of
macrophages in adipose tissue, an event associated with a
development of metabolic disorders (6, 49, 50). The MCP-1
protein levels were significantly higher in the obese mice than
those in the lean controls and the concentration of MCP-1 in
these mice far exceeded that determined in mesenteric adipose
tissue of lean mice (51). This reduction in MCP-1 expression in
adipocytes co-incubated with irisin observed in our study can
significantly contribute to the anti-inflammatory action of irisin
and supports the protective activity of this peptide released from
skeletal muscle during exercise especially in obese individuals.
This local anti-inflammatory activity of irisin is in keeping with
recent observation that this peptide is not associated with
depressiveness, anxiety and perceived stress in female obese
patients ruling out the assumption of irisin being involved in
mental functions and psychoendocrine pathways (52).
In conclusion, we confirmed the anti-inflammatory activity
of irisin in adipocytes. We demonstrated for the first time that
irisin can directly attenuate the inflammation process in
cultured adipocytes, in addition to inhibition of migratory
activity of macrophages the action to this myozine that has been
shown before.
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